Gary Gilliland plans to step down as president and director of the Fred Hutchinson Cancer Research Center in Seattle in 2020. Prior to working at the Hutch, Gilliland served as director of the leukemia program at Dana-Farber/Harvard Cancer, senior VP and global oncology franchise head at Merck, and vice dean and VP of precision medicine at the Perelman School of Medicine at the University of Pennsylvania.